Improved pharmacokinetic profile of levornidazole following intravenous infusion of 750mg every 24h compared with 500mg every 12h in healthy Chinese volunteers (English)
- New search for: Cao, Y.
- New search for: Wu, X.
- New search for: Chen, Y.
- New search for: Guo, B.
- New search for: Yu, J.
- New search for: Cao, G.
- New search for: Zhang, J.
- New search for: Shi, Y.
- New search for: Zhang, Y.
- New search for: Cao, Y.
- New search for: Wu, X.
- New search for: Chen, Y.
- New search for: Guo, B.
- New search for: Yu, J.
- New search for: Cao, G.
- New search for: Zhang, J.
- New search for: Shi, Y.
- New search for: Zhang, Y.
In:
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
;
47
, 3
;
224-228
;
2016
-
ISSN:
- Article (Journal) / Print
-
Title:Improved pharmacokinetic profile of levornidazole following intravenous infusion of 750mg every 24h compared with 500mg every 12h in healthy Chinese volunteers
-
Contributors:
-
Published in:INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS ; 47, 3 ; 224-228
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2016-01-01
-
Size:5 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 579
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 579 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 47, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 171
-
Antibiotic administration and the development of obesity in childrenPrincipi, N. / Esposito, S. et al. | 2016
- 178
-
In vitro pharmacodynamic modelling of anidulafungin against Candida spp.Gil-Alonso, S. / Jauregizar, N. / Ortega, I. / Eraso, E. / Suárez, E. / Quindós, G. et al. | 2016
- 184
-
A model-based meta-analysis of sofosbuvir-based treatments in chronic hepatitis C patientsPérez-Pitarch, A. / Guglieri-López, B. / Ferriols-Lisart, R. / Merino-Sanjuán, M. et al. | 2016
- 195
-
Repurposing auranofin for the treatment of cutaneous staphylococcal infectionsThangamani, S. / Mohammad, H. / Abushahba, M. F. / Sobreira, T. J. / Seleem, M. N. et al. | 2016
- 202
-
Optimal dosing regimen of biapenem in Chinese patients with lower respiratory tract infections based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulationDong, J. / Xiong, W. / Chen, Y. / Zhao, Y. / Lu, Y. / Zhao, D. / Li, W. / Liu, Y. / Chen, X. et al. | 2016
- 210
-
Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern ChinaOuyang, W. / Xue, H. / Chen, Y. / Gao, W. / Li, X. / Wei, J. / Wen, Z. et al. | 2016
- 217
-
Synergistic activity of antibiotics combined with ivermectin to kill body liceSangaré, A. K. / Rolain, J. M. / Gaudart, J. / Weber, P. / Raoult, D. et al. | 2016
- 224
-
Improved pharmacokinetic profile of levornidazole following intravenous infusion of 750mg every 24h compared with 500mg every 12h in healthy Chinese volunteersCao, Y. / Wu, X. / Chen, Y. / Guo, B. / Yu, J. / Cao, G. / Zhang, J. / Shi, Y. / Zhang, Y. et al. | 2016
- 229
-
Flucloxacillin does not achieve therapeutic cerebrospinal fluid levels against meticillin-sensitive Staphylococcus aureus in adults: A case report and review of the literatureChew, R. / Woods, M. L. et al. | 2016
- 232
-
In vitro effect of octenidine dihydrochloride against Trichomonas vaginalisKüng, E. / Pietrzak, J. / Klaus, C. / Walochnik, J. et al. | 2016
- 235
-
In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patientsFlamm, R. K. / Nichols, W. W. / Sader, H. S. / Farrell, D. J. / Jones, R. N. et al. | 2016
- 243
-
Reply to: Re: The challenge of Clostridium difficile infection: overview of clinical manifestations, diagnostic tools and therapeutic optionsPostma, N. / Kiers, D. / Pickkers, P. et al. | 2016
- 243
-
Re: The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic optionsDi Bella, S. / Gori, A. et al. | 2016
- 244
-
First description of CTX-M-3 extended-spectrum β-lactamase in an outbreak strain of Shiga toxin-producing Escherichia coli O103:H2Kim, J. S. / Kim, M. J. / Kim, S. J. / Shin, E. / Oh, K. H. / Kim, S. G. / Chung, G. T. / Yoo, C. K. / Seo, K. W. / Kim, J. et al. | 2016
- 245
-
Detection of translocatable units in a blaCTX-M-15 extended-spectrum β-lactamase-producing ST131 Escherichia coli isolate using a hybrid sequencing approachGhosh, H. / Doijad, S. / Bunk, B. / Falgenhauer, L. / Yao, Y. / Spröer, C. / Gentil, K. / Schmiedel, J. / Imirzalioglu, C. / Overmann, J. r. et al. | 2016
- 247
-
Tissue penetration and exposure of cefepime in patients with diabetic foot infectionsSo, W. / Kuti, J. L. / Shepard, A. / Nugent, J. / Nicolau, D. P. et al. | 2016
- i
-
Title Page & Editorial Board| 2016